| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 14 |
| 1 | ADALIMUMAB-AATY | 13 |
| 2 | ADALIMUMAB-ADAZ | 13 |
| 3 | ADALIMUMAB-FKJP | 13 |
| 4 | INFLIXIMAB | 9 |
| 5 | NIVOLUMAB | 8 |
| 6 | METHOTREXATE | 5 |
| 7 | METHOTREXATE SODIUM | 5 |
| 8 | REPOSITORY CORTICOTROPIN | 5 |
| 9 | IPILIMUMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REPOSITORY CORTICOTROPIN | 5 | 0.0011 |
| 1 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 2 | BARICITINIB | 1 | 0.0003 |
| 3 | ADALIMUMAB-FKJP | 13 | 0.0003 |
| 4 | ADALIMUMAB-AATY | 13 | 0.0003 |
| 5 | ADALIMUMAB-ADAZ | 13 | 0.0002 |
| 6 | RALTEGRAVIR | 1 | 0.0002 |
| 7 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 8 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 9 | OFLOXACIN OTIC | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 5 | 0.0056 |
| 1 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 8 | 0.0001 |
| 4 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 5 | Antirheumatic Agent [EPC] | 3 | 0.0000 |
| 6 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 25 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 3 | 0.0000 |